Punch in the Gut Impact of PGR ruling on microbiome therapeutics



Date: April 21, 2020

Time: 11:30 am–12:30 pm Eastern/8:30–9:30 am Pacific

Location: Webinar (Access instructions e-mailed upon registration)

Contact: Kristen DeCandia
kdecandia@nixonpeabody.com
617-345-1232

By April 15, 2020, the USPTO will rule on the first-ever challenge to a microbiome therapeutics patent in the U.S.—Genome & Co. v. University of Chicago.

Join us on April 21 for a webinar presented by Mark FitzGerald, a partner at Nixon Peabody, and members of the HGF Microbiome IP Team. Mark will examine the ruling and its impact on patents covering microbiome therapeutics in the U.S., and the HGF Microbiome IP team will provide perspective regarding challenges to patents covering similar subject matter in the European Patent Office.

Our Speakers

Continuing Education

This course is eligible for 1.0 credit. Click here for continuing education details.

Back to top